NR1H4 and Hypercholesterolemia: Although study has reported that upregulating FXR in diabetic mice can significantly improve hypercholesterolemia [263], other study found that inhibition of intestinal FXR can reduce hepatic gluconeogenesis, promote the secretion of GLP-1, and reduce body weight [264].